LRP6 and glioblastoma: Additionally, exploring the modulatory function of microRNAs on the Wnt/β‐catenin signaling pathway, a recent study demonstrated that miR‐137 targets LRP6 and effectively inhibits GBM growth and temozolomide (TMZ) resistance [34].